Tech Company Financing Transactions

Glycomine Funding Round

Glycomine, based in San Carlos, raised $115 million from Advent Life Sciences, CTI Life Sciences Fund and Abingworth.

Transaction Overview

Company Name
Glycomine
Announced On
4/16/2025
Transaction Type
Venture Equity
Amount
$115,000,000
Round
Series C
Investors

Advent Life Sciences (Lead Investor) (Dominic Schmidt)

CTI Life Sciences Fund (Lead Investor) (Youssef Bennani)

Abingworth

Asahi Kasei

Chiesi Ventures (Giacomo Chiesi)

Novo Holdings

Remiges Ventures

RiverVest Venture Partners

Sanderling Ventures (Peter McWilliams)

Sanofi Ventures

Proceeds Purpose
The company intends to use the funds to advance its lead candidate, GLM101, into a Phase 2b clinical trial.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
733 Industrial Rd.
San Carlos, CA 94070
USA
Phone
(650) 401-2016
Website
www.glycomine.com
Email Address
[email protected]
Overview
Glycomine is developing orphan drugs for serious rare monogenic disorders of metabolism and protein misfolding for which no other therapeutic options exist.
Profile
Glycomine LinkedIn Company Profile
Social Media
Glycomine Company Twitter Account
Company News
Glycomine News
Facebook
Glycomine on Facebook
YouTube
Glycomine on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Peter McWilliams
  Peter McWilliams LinkedIn Profile  Peter McWilliams Twitter Account  Peter McWilliams News  Peter McWilliams on Facebook
Chief Medical Officer
Horacio Plotkin
  Horacio Plotkin LinkedIn Profile  Horacio Plotkin Twitter Account  Horacio Plotkin News  Horacio Plotkin on Facebook
Vice President
Geoffrey Hird
  Geoffrey Hird LinkedIn Profile  Geoffrey Hird Twitter Account  Geoffrey Hird News  Geoffrey Hird on Facebook
VP - Regulatory Affairs
Lisa Koch-Hulle
  Lisa Koch-Hulle LinkedIn Profile  Lisa Koch-Hulle Twitter Account  Lisa Koch-Hulle News  Lisa Koch-Hulle on Facebook

 

 

Browse more venture capital transactions:

Prev: 4/16/2025: EF Polymer venture capital transaction
Next: 4/16/2025: Hammerspace venture capital transaction

 

Share this article

 

News on VC Transactions

We do our best to report on every notable VC transaction. All VC database entries on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2025. Gaebler Ventures. All rights reserved.